RecruitingNCT06187831

Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger

Changes in Central Venous Catheterization Bleeding Events After Implementing a Lower Trigger For Platelet Transfusion - an Observational Study


Sponsor

Thomas Kander

Enrollment

500 participants

Start Date

Feb 26, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Central venous catheters are essential when administering treatment for hematological conditions. Many patients have a decreased platelet count which increases the risk for bleeding complications. Baarle et al. recently published a randomized controlled study where withholding prophylactic platelet transfusions before CVC placement in patients with a platelet count of 10,000 to 50,000 per cubic millimeter did not meet the predefined margin for non-inferiority for postprocedural bleeding events (PMID: 37224197). However, bleedings grade 2 (defined as bleeding that requires external compression) were included despite lacking clinical significance. The aim of the present study is to investigate whether lowering the preprocedural platelet transfusion trigger from 50x10\^9/L to 10x10\^9/L for insertions of central venous catheters remains safe with regards to postprocedural bleeding events of grade 3-4.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • ≥ 18 years of age
  • Indication for central venous catheter placement.
  • Patients admitted to a hematological ward at the current department

Exclusion Criteria1

  • Death within 24h after insertion of CVC.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Thomas Kander

Lund, Lunds Universitet, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06187831


Related Trials